Related Experiment Videos
Monotherapy and combined treatment with captopril
1Third Department of Internal Medicine, Weil Emil Hospital, Budapest, Hungary.
Acta Physiologica Hungarica
|January 1, 1988
Summary
Captopril is an effective antihypertensive drug for managing hypertension, suitable for monotherapy or combination treatment, with a favorable safety profile and manageable side effects like elevated potassium levels.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Hypertension management requires effective antihypertensive agents.
- Captopril is an angiotensin-converting enzyme (ACE) inhibitor used for hypertension.
Purpose of the Study:
- To investigate the effectiveness, dose-response, and combination therapy of captopril in hypertensive patients.
- To evaluate the clinical value of captopril monotherapy versus combined treatment.
Main Methods:
- Clinico-pharmacological studies conducted over four years (1982-1986).
- Involved 48 patients with hypertension.
- Assessed captopril's efficacy, dosage, interactions with diuretics and other antihypertensives.
Main Results:
- Captopril demonstrated a wide therapeutic spectrum as an antihypertensive agent.
- It was particularly useful as monotherapy in geriatric patients.
- Diuretics were the most frequent combination, but captopril was compatible with most antihypertensives.
- Captopril was generally safe with few significant side effects.
- Increased serum potassium levels were observed, with detailed discussion on prevention and mechanisms.
Conclusions:
- Captopril is a safe and effective antihypertensive agent.
- It offers flexibility in monotherapy and combination treatments.
- Careful monitoring for potassium levels is advised.